Protara Therapeutics (TARA) Short Interest Ratio & Short Volume $4.92 +0.42 (+9.33%) Closing price 01/31/2025 04:00 PM EasternExtended Trading$4.94 +0.03 (+0.51%) As of 01/31/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Protara Therapeutics Short Interest DataProtara Therapeutics (TARA) has a short interest of 4.40 million shares. This marks a -13.73% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.9, indicating that it would take 1.9 days of the average trading volume of 313,754 shares to cover all short positions.Current Short Interest4,400,000 sharesPrevious Short Interest5,100,000 sharesChange Vs. Previous Month-13.73%Dollar Volume Sold Short$20.55 millionShort Interest Ratio1.9 Days to CoverLast Record DateJanuary 15, 2025Outstanding Shares20,630,000 sharesPercentage of Shares Shorted21.33%Today's Trading Volume533,393 sharesAverage Trading Volume313,754 sharesToday's Volume Vs. Average170% Short Selling Protara Therapeutics? Sign up to receive the latest short interest report for Protara Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTARA Short Interest Over TimeTARA Days to Cover Over TimeTARA Percentage of Float Shorted Over Time Protara Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/15/20254,400,000 shares $20.55 million -13.7%N/A1.9 $4.67 12/31/20245,100,000 shares $26.93 million -5.7%N/A2.3 $5.28 12/15/20245,410,000 shares $32.35 million +79.1%N/A2.5 $5.98 11/30/20243,020,000 shares $9.09 million +10.6%N/A1.5 $3.01 11/15/20242,730,000 shares $6.74 million -0.4%N/A16.2 $2.47 10/31/20242,740,000 shares $6.88 million +18.1%N/A15.3 $2.51 10/15/20242,320,000 shares $4.15 million +7.9%N/A14.2 $1.79 9/30/20242,150,000 shares $3.93 million +2.4%N/A13.7 $1.83 9/15/20242,100,000 shares $3.95 million +2.4%N/A12.9 $1.88 8/31/20242,050,000 shares $4.10 million +9.0%N/A12.3 $2.00 Get the Latest News and Ratings for TARA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Protara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/15/20241,880,000 shares $3.85 million +8.1%N/A10.7 $2.05 7/31/20241,740,000 shares $3.88 million -3.3%N/A6.9 $2.23 7/15/20241,800,000 shares $4.28 million +1.7%N/A6.3 $2.38 6/30/20241,770,000 shares $3.68 million +2.9%N/A5.9 $2.08 6/15/20241,720,000 shares $4.42 million +8.9%N/A4.2 $2.57 5/31/20241,580,000 shares $4.44 million +16.2%N/A4 $2.81 5/15/20241,360,000 shares $5.05 million +32.0%N/A3.6 $3.71 4/30/20241,030,000 shares $3.07 million +158.6%N/A3.5 $2.98 4/15/2024398,300 shares $1.13 million +510.9%4.4%1.6 $2.84 3/31/202465,200 shares $261,452.00 +6.2%0.7%0.3 $4.01 3/15/202461,400 shares $225,952.00 -22.3%0.7%0.8 $3.68 2/29/202479,000 shares $360,240.00 +33.9%0.9%1.1 $4.56 2/15/202459,000 shares $208,270.00 -33.0%0.7%0.8 $3.53 1/31/202488,100 shares $224,655.00 +19.2%1.1%1.5 $2.55 1/15/202473,900 shares $170,709.00 +1.5%0.9%1.3 $2.31 12/31/202372,800 shares $136,507.28 +46.8%0.9%1.3 $1.88 12/15/202349,600 shares $88,288.00 -16.2%0.6%1.1 $1.78 11/30/202359,200 shares $85,840.00 +22.3%0.7%1.6 $1.45 11/15/202348,400 shares $58,080.00 +1.7%0.6%1.6 $1.20 10/31/202347,600 shares $59,271.52 -3.3%0.6%1.9 $1.25 10/15/202349,200 shares $81,180.00 -4.3%0.6%2.5 $1.65 9/30/202351,400 shares $85,838.00 +5.5%0.6%2.2 $1.67 9/15/202348,700 shares $90,095.00 -7.4%0.6%1.8 $1.85 8/31/202352,600 shares $114,668.00 +14.4%0.6%1.8 $2.18 8/15/202346,000 shares $109,020.00 -40.8%0.6%1.4 $2.37 7/31/202377,700 shares $201,243.00 -28.5%0.9%2.3 $2.59 7/15/2023108,600 shares $298,650.00 +10.0%1.3%2.9 $2.75 6/30/202398,700 shares $235,893.00 -9.0%1.2%2.7 $2.39 6/15/2023108,400 shares $308,940.00 +11.0%1.3%3.2 $2.85 5/31/202397,700 shares $272,583.00 +0.2%1.2%2.7 $2.79Is this Elon’s true agenda? (Ad)All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors have all turned to my business partner and I for our thoughts on the market. And with every investor in America wondering what Elon is going to do now that he's in Washington, this is what we tell themClick here for my report 5/15/202397,500 shares $328,575.00 -4.6%1.2%2.6 $3.37 4/30/2023102,200 shares $322,952.00 +34.1%1.2%3.2 $3.16 4/15/202376,200 shares $221,742.00 -0.4%0.9%2.4 $2.91 3/31/202376,500 shares $239,445.00 -0.4%0.9%3.2 $3.13 3/15/202376,800 shares $235,776.00 -0.9%0.9%3.2 $3.07 2/28/202377,500 shares $273,575.00 -5.8%0.9%4.2 $3.53 2/15/202382,300 shares $264,183.00 -2.4%0.9%4.5 $3.21 1/31/202384,300 shares $275,239.50 -0.6%1.0%3.5 $3.27 1/15/202384,800 shares $284,928.00 -1.5%1.0%3.2 $3.36 12/30/202286,100 shares $230,748.00 +8.4%1.0%3 $2.68 12/15/202279,400 shares $243,758.00 -30.8%0.9%2.5 $3.07 11/30/2022114,700 shares $404,891.00 +22.7%1.3%3 $3.53 11/15/202293,500 shares $276,760.00 +7.5%1.0%2.2 $2.96 10/31/202287,000 shares $267,090.00 +2.7%1.0%2 $3.07 10/15/202284,700 shares $281,204.00 -16.6%1.0%2.1 $3.32 9/30/2022101,600 shares $300,736.00 -9.5%1.2%2.8 $2.96 9/15/2022112,200 shares $433,092.00 +14.5%1.3%2.6 $3.86 8/31/202298,000 shares $338,100.00 +9.0%1.2%2.3 $3.45 8/15/202289,900 shares $311,953.00 -1.0%1.1%2.4 $3.47 7/31/202290,800 shares $271,492.00 -32.7%1.1%2.4 $2.99 7/15/2022135,000 shares $422,550.00 +32.1%1.6%3.6 $3.13 6/30/2022102,200 shares $299,446.00 -32.4%1.2%2.7 $2.93 6/15/2022151,200 shares $471,744.00 -5.0%1.8%4.7 $3.12 5/31/2022159,200 shares $531,728.00 +5.5%1.9%5.6 $3.34 5/15/2022150,900 shares $436,101.00 +1.6%1.8%4.9 $2.89 4/30/2022148,500 shares $543,510.00 -6.8%1.8%4.9 $3.66 4/15/2022159,400 shares $730,052.00 -15.5%1.9%4.8 $4.58 3/31/2022188,700 shares $964,257.00 -8.0%2.2%5 $5.11 3/15/2022205,100 shares $916,797.00 -30.4%2.4%3.9 $4.47 2/28/2022294,500 shares $1.36 million +17.9%3.5%5.1 $4.63 2/15/2022249,900 shares $1.31 million -10.3%3.0%4 $5.25 1/31/2022278,500 shares $1.45 million -8.3%3.2%3.7 $5.21 1/15/2022303,700 shares $1.93 million -19.8%3.4%3.5 $6.37 12/31/2021378,600 shares $2.56 million -3.1%4.2%1.2 $6.75 12/15/2021390,700 shares $2.56 million +32.3%4.3%1.3 $6.56 11/30/2021295,300 shares $2.03 million -7.4%3.2%0.9 $6.89 11/15/2021318,800 shares $2.28 million -11.4%3.5%1 $7.15 10/29/2021359,600 shares $2.49 million -20.7%4.0%1.1 $6.92 10/15/2021453,400 shares $3.10 million +249.9%5.0%1.4 $6.84 9/30/2021129,600 shares $896,832.00 -36.0%1.4%1.2 $6.92 9/15/2021202,600 shares $1.44 million -1.9%2.2%1.8 $7.10 8/31/2021206,600 shares $1.73 million +9.3%2.3%2.3 $8.39 8/13/2021189,000 shares $1.33 million -2.3%2.1%1.9 $7.03 7/30/2021193,400 shares $1.53 million +1.9%2.1%2.1 $7.93 7/15/2021189,800 shares $1.61 million +27.9%2.0%1.4 $8.48 6/30/2021148,400 shares $1.45 million -52.2%1.6%1 $9.74 6/15/2021310,700 shares $3.26 million +2.4%3.3%2.3 $10.49 5/28/2021303,300 shares $2.88 million -1.1%3.2%2.2 $9.48 5/14/2021306,800 shares $2.66 million -10.7%3.2%2.4 $8.68 4/30/2021343,400 shares $3.91 million +20.2%3.5%2.6 $11.39Is this Elon’s true agenda? (Ad)All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors have all turned to my business partner and I for our thoughts on the market. And with every investor in America wondering what Elon is going to do now that he's in Washington, this is what we tell themClick here for my report 4/15/2021285,700 shares $4.85 million -1.1%2.9%2.4 $16.99 3/31/2021288,900 shares $4.07 million +38.8%3.0%3.1 $14.10 3/15/2021208,200 shares $3.71 million +34.2%2.1%2.1 $17.82 2/26/2021155,100 shares $2.73 million +14.1%1.6%1.6 $17.61 2/12/2021135,900 shares $2.77 million +0.3%1.4%1.5 $20.37 1/29/2021135,500 shares $2.56 million +25.1%1.4%1.4 $18.88 1/15/2021108,300 shares $2.18 million -2.0%1.1%1.2 $20.14 12/31/2020110,500 shares $2.67 million +83.3%1.2%1.2 $24.15 12/15/202060,300 shares $1.34 million +45.0%0.6%0.5 $22.17 11/30/202041,600 shares $965,120.00 -19.2%0.4%0.4 $23.20 11/15/202051,500 shares $1.11 million +12.5%0.5%0.5 $21.48 10/30/202045,800 shares $854,628.00 +23.8%0.5%0.5 $18.66 10/15/202037,000 shares $696,710.00 +6.6%0.4%0.5 $18.83 9/30/202034,700 shares $584,001.00 -28.8%0.4%0.6 $16.83 9/15/202048,700 shares $946,728.00 -6.4%1.1%1.4 $19.44 8/31/202052,000 shares $1.11 million -7.6%1.2%1.8 $21.40 8/14/202056,300 shares $1.35 million -8.8%1.3%1.9 $24.00 7/31/202061,700 shares $1.54 million +23.7%1.5%2.1 $24.94 7/15/202049,900 shares $1.33 million +7.8%1.2%2 $26.67 6/30/202046,300 shares $1.43 million +223.8%1.1%1.9 $30.80 6/15/202014,300 shares $434,148.00 +210.9%0.4%0.8 $30.36 5/29/20204,600 shares $223,054.00 +12.2%0.1%0.3 $48.49 5/15/20204,100 shares $98,605.00 +86.4%0.1%0.4 $24.05 4/30/20202,200 shares $53,900.00 -42.1%0.1%0.2 $24.50 4/15/20203,800 shares $91,200.00 -33.3%0.1%0.3 $24.00 3/31/20205,700 shares $136,629.00 +42.5%0.1%0.4 $23.97 3/13/20204,000 shares $89,240.00 +400.0%0.8%0.4 $22.31 2/28/2020800 shares $16,816.00 -89.2%0.2%0.1 $21.02 2/14/20207,400 shares $179,080.00 +1.4%1.4%0.5 $24.20 TARA Short Interest - Frequently Asked Questions What is Protara Therapeutics' current short interest? Short interest is the volume of Protara Therapeutics shares that have been sold short but have not yet been covered or closed out. As of January 15th, traders have sold 4,400,000 shares of TARA short. Learn More on Protara Therapeutics' current short interest. What is a good short interest ratio for Protara Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TARA shares currently have a short interest ratio of 2.0. Learn More on Protara Therapeutics's short interest ratio. Which institutional investors are shorting Protara Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Protara Therapeutics: Wolverine Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Protara Therapeutics' short interest increasing or decreasing? Protara Therapeutics saw a decline in short interest in the month of January. As of January 15th, there was short interest totaling 4,400,000 shares, a decline of 13.7% from the previous total of 5,100,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Protara Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Protara Therapeutics: Chimerix, Inc. (2.70%), Olema Pharmaceuticals, Inc. (18.97%), Korro Bio, Inc. (13.49%), Monte Rosa Therapeutics, Inc. (19.06%), Conduit Pharmaceuticals Inc. (4.48%), Tango Therapeutics, Inc. (14.08%), Corvus Pharmaceuticals, Inc. (8.56%), Neumora Therapeutics, Inc. (19.99%), biote Corp. (2.61%), Taysha Gene Therapies, Inc. (11.69%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($4.18 billion), Charter Communications, Inc. ($3.91 billion), Reddit, Inc. ($3.16 billion), The Kroger Co. ($2.75 billion), International Paper ($2.57 billion), Cencora, Inc. ($2.06 billion), SoFi Technologies, Inc. ($2.06 billion), Rivian Automotive, Inc. ($2.00 billion), Live Nation Entertainment, Inc. ($1.63 billion), and Hims & Hers Health, Inc. ($1.57 billion). View all of the most shorted stocks. What does it mean to sell short Protara Therapeutics stock? Short selling TARA is an investing strategy that aims to generate trading profit from Protara Therapeutics as its price is falling. TARA shares are trading up $0.42 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Protara Therapeutics? A short squeeze for Protara Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TARA, which in turn drives the price of the stock up even further. How often is Protara Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TARA, twice per month. The most recent reporting period available is January, 15 2025. More Short Interest Resources from MarketBeat Related Companies CMRX Short Squeeze OLMA Short Squeeze KRRO Short Squeeze GLUE Short Squeeze CDT Short Squeeze TNGX Short Squeeze CRVS Short Squeeze NMRA Short Squeeze BTMD Short Squeeze TSHA Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TARA) was last updated on 2/1/2025 by MarketBeat.com Staff From Our PartnersElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredWill DeepSeek pop the AI bubble?An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump vs. TexasEver since Donald Trump won the election, U.S. states have been rushing to pass new currency rules. These r...Stansberry Research | SponsoredTurning Panic Into OpportunityAI stocks were hammered on Jan. 27. That includes Nvidia, the undisputed leader in the artificial intellige...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredWill Elon trigger another AI flash crash?AI continues to dominate financial headlines in 2025...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Protara Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Protara Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
